Riskpilot← Back to searchSign inGet full accessREFLAB ApS
APSActiveCVR 15322586Kanalholmen 1, 2.Traditional, complementary and alternative medicine activities · NACE 8696Est. 199111 employeeswww.reflab.dk
Revenue 2025
DKK 4,6M
-23% vs 2024
EBITDA margin
-40.3%
-231% vs 2024
Equity ratio
-14.1%
Financial strength
Net profit 2025
DKK -1,8M
-375% vs 2024
| Revenue | DKK 4,6M | -23% |
| EBITDA | DKK -1,8M | -231% |
| Net profit | DKK -1,8M | -375% |
| Total assets | DKK 4,5M | -29% |
| Equity | DKK -635K | -155% |
| Employees | 11 | — |
Legal name
REFLAB ApS
CVR number
15322586
Legal form
Anpartsselskab
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
22. april 1991
Share capital
DKK 200.000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af 2 direktører i forening eller af én direktør alene.
Company purpose
Selskabets formål er at drive laboratorievirksomhed ved udførelse af klinisk kemiske analyser, herunder produktion af diagnostiske kits til udførelse af nævnte analyser samt anden dermed i forbindelse stående virksomhed.
Address
Kanalholmen 1, 2.
Phone
+4570702345
Email
info@reflab.dk
Website
www.reflab.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.529 | 3.659 | 4.639 | 2.968 | 1.733 | 2.783 | 3.309 | 6.891 | 1.851 | 3.435 | 3.217 | 3.456 | 5.922 | 4.582 |
| Staff expenses | -2.411 | -3.082 | -3.080 | -3.294 | -3.343 | -3.608 | -3.538 | -3.405 | -2.727 | -3.633 | -3.679 | -3.905 | -4.478 | -6.415 |
| EBITDA | 118 | 577 | 1.559 | -326 | -1.610 | -825 | -230 | 3.486 | -876 | -198 | -462 | -731 | 1.408 | -1.845 |
| Depreciation & amort. | -201 | -434 | -98 | -155 | -123 | -148 | -153 | -270 | -269 | -235 | -283 | -371 | -341 | -306 |
| EBIT | -83 | 143 | 1.461 | -480 | -1.732 | -973 | -383 | 3.216 | -1.145 | -433 | -745 | -1.102 | 1.067 | -2.151 |
| Net financials | -0 | -12 | -20 | -6 | -25 | -58 | -77 | -74 | -77 | -3 | -83 | -98 | -230 | -146 |
| Profit before tax | -83 | 131 | 1.440 | -486 | -1.757 | -1.031 | -460 | 3.142 | -1.222 | -436 | -828 | -1.199 | 837 | -2.298 |
| Tax | -19 | 33 | 360 | -105 | 45 | -23 | -34 | 68 | -333 | -95 | -182 | -264 | 184 | -505 |
| Net profit | -65 | 98 | 1.081 | -382 | -1.803 | -1.008 | -426 | 3.074 | -888 | -341 | -646 | -936 | 653 | -1.792 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3.543 | 3.712 | 5.070 | 4.291 | 3.436 | 4.293 | 4.127 | 7.337 | 6.241 | 5.823 | 5.175 | 5.811 | 6.380 | 4.506 |
| Equity | 2.683 | 2.781 | 3.861 | 3.480 | 1.677 | 669 | 242 | 3.316 | 2.428 | 2.087 | 1.440 | 505 | 1.157 | -635 |
| Long-term debt | 274 | 486 | 814 | 330 | 450 | 0 | 0 | 2.883 | 255 | 0 | 2.748 | 2.748 | 3.501 | 2.697 |
| Short-term debt | 852 | 931 | 1.208 | 811 | 1.309 | 3.624 | 3.885 | 1.137 | 3.559 | 3.736 | 970 | 2.509 | 1.617 | 2.395 |
| Total debt | 852 | 931 | 1.208 | 811 | 1.759 | 3.624 | 3.885 | 4.020 | 3.813 | 3.736 | 3.718 | 5.258 | 5.118 | 5.091 |
EBITDA margin
-40.3%
This company
15.8%
Market median
-355% vs market
20122025
Equity ratio
-14.1%
This company
38.2%
Market median
-137% vs market
20122025
Return on equity
-179243000.0%
This company
18.4%
Market median
-974146839% vs market
20122025
Net profit margin
-39.1%
This company
8.1%
Market median
-583% vs market
20122025
Asset turnover
1.02×
This company
1.12×
Market median
+9% vs market
20122025
Debt / equity
8.10×
This company
0.62×
Market median
-1206% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HC Management | Management | 2019 | — | — |
PS Founder | Founder | 1991 | — | — |
EV Management | Management | 2003 | — | — |
ED Management | Management | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 1991 | — | — | |
| Board of Directors | 2000 | — | — | |
| Board of Directors | 1991 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of REFLAB ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Christensen | Management | 0 companies |
| Per Stahl Skov | Founder | 0 companies |
| Eva Valbjørn Sørensen | Management | 0 companies |
| Erik Dahl Jensen | Management | 0 companies |
| Hendrik Kees Kam Nolte | Board of Directors | 0 companies |
| Eivind Frederik Kramme | Board of Directors | 0 companies |
| Dorte Eldal Rødsgaard | Board of Directors | 0 companies |